| 证券代码：603368 | 证券简称：柳药集团 | 公告编号：2025-061 | | --- | --- | --- | | 转债代码：113563 | 转债简称：柳药转债 | | 广西柳药集团股份有限公司 关于以集中竞价交易方式回购股份比例达到 1%暨 回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/7/26 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 月 2025 7 7 | 25 | 日~2026 | 年 | 月 | 24 | 日 | | 预计回购金额 | 10,000万元~20,000万元 □减少注册资本 | | | | | | | | 回购用途 | √用于员工持股计划或股权激励 | | | | | | | | | □用于转换公司可转债 | | | | | | | | | □为维护公司价值及股东权益 | | | | | | | | 累 ...

Market Overview - The Shanghai Composite Index increased by 2.11% to close at 3635.13 points, with a weekly high of 3645.37 points [1] - The Shenzhen Component Index rose by 1.25% to 11128.67 points, reaching a peak of 11229.59 points [1] - The ChiNext Index saw a 0.49% increase, closing at 2333.96 points, with a maximum of 2372.68 points [1] - Global markets also experienced gains, with the Nasdaq Composite up by 3.87%, the Dow Jones Industrial Average rising by 1.35%, and the S&P 500 increasing by 2.43% [1] - In the Asia-Pacific region, the Hang Seng Index rose by 1.43% and the Nikkei 225 increased by 2.5% [1] New Stock Issuance - One new stock was issued last week: Zhigao Machinery (920101.BJ) on August 5, 2025 [2] Margin Trading - The total margin trading balance in the Shanghai and Shenzhen markets reached 20031.09 billion yuan, with a financing balance of 19889.53 billion yuan and a securities lending balance of 141.56 billion yuan [3] - The margin trading balance increased by 294.86 billion yuan compared to the previous week [3] - The top three stocks by financing purchase amount were Northern Rare Earth (58.53 billion yuan), Zhongji Xuchuang (49.9 billion yuan), and Dongfang Fortune (48.27 billion yuan) [3][4] Fund Issuance - A total of 21 new funds were issued last week, including various index funds and mixed funds [5] - Notable funds include Ping An Ru Yi Short-term Bond Fund and Penghua CSI Bank Index Fund [5][6] Company Buybacks - There were 23 buyback announcements last week, with the highest amounts executed by Junxin Environmental Protection (50.99 million yuan), Mianbao (12.13 million yuan), and Runze Technology (10.47 million yuan) [7] - The sectors with the highest buyback amounts were Environmental Protection, Pharmaceutical Biology, and Electronics [7][8]

Group 1 - The company provided guarantees totaling 74.32 million yuan for its subsidiaries to support their production and business development needs, while also releasing guarantees amounting to 25.70 million yuan [2][3] - The company has a total guarantee limit of up to 7 billion yuan for the year 2025, which was approved in the shareholders' meeting [3][4] - The guarantees are deemed necessary and reasonable as they align with the company's overall interests and development strategy, with the subsidiaries being under the company's absolute control [4][5] Group 2 - As of the announcement date, the total external guarantees provided by the company and its subsidiaries amounted to 2.70 billion yuan, representing 35.46% of the company's latest audited net assets [6] - The company does not have any overdue guarantees and has not provided guarantees for its controlling shareholders or related parties [6] Group 3 - The controlling shareholder, Mr. Zhu Chaoyang, holds 101,032,795 shares, accounting for 25.44% of the total share capital, and has pledged 28,660,000 shares, which is 28.37% of his holdings [9][10] - The pledge of shares has been extended, with the repurchase date set for August 21, 2025, and no new financing arrangements are involved [10][11] - Mr. Zhu's personal credit status is good, and he has the ability to repay, with no current risk of forced liquidation [12]

证券日报网讯 8月8日晚间，柳药集团发布公告称，2025年7月，为支持广西柳药集团股份有限公司下属 控股子公司的生产经营和业务发展需要，公司就下属控股子公司向银行申请综合授信等事项合计新增 7，432.48万元的担保，同时解除担保金额合计2，570.01万元。截至本公告日，公司及下属控股子公司 对外担保总额为270，383.14万元，占公司最近一期经审计净资产的35.46%，其中公司对下属控股子公 司提供的担保总额为254，852.31万元，占公司最近一期经审计净资产的33.43%。 （文章来源：证券日报） ...

| 证券代码：603368 | 证券简称：柳药集团 | 公告编号：2025-060 | | --- | --- | --- | | 转债代码：113563 | 转债简称：柳药转债 | | 广西柳药集团股份有限公司 关于控股股东部分股份解除质押及质押延期购回的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 广西柳药集团股份有限公司（以下简称"公司"）控股股东暨实际控制人 朱朝阳先生持有本公司股份 101,032,795 股，占公司目前总股本的 25.44%。本次 解除质押及质押延期购回后，朱朝阳先生累计质押公司股份 28,660,000 股，占其 所持有公司股份的 28.37%，占公司目前总股本的 7.22%。前述质押股份将质押 延期购回业务。 近日，公司接到控股股东朱朝阳先生关于将其所持部分公司股份办理解除质 押及质押延期购回业务的通知。具体情况如下： （www.sse.com.cn）及指定媒体上披露的相关公告（公告编号：2023-088、 2024-079）。 一、本次股份解除质押基本情况 ...

广西柳药集团股份有限公司 关于为下属控股子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 | | 广西南宁柳药药业有限公司（简称"南宁柳药"） | | --- | --- | --- | --- | | | 本次担保金额 | 1,432.48 | 万元 | | 担保 对象一 | 实际为其提供的担保余额 | 155,862.31 | 万元（含本次） | | | 是否在前期预计额度内 | 是 □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 否 | □不适用：_________ | | 担保 | 被担保人名称 | | 广西仙茱制药有限公司（简称"仙茱制药"） | | | 本次担保金额 | 3,000.00 | 万元 | | 对象二 | 实际为其提供的担保余额 | 8,000.00 | 万元（含本次） | | | 是否在前期预计额度内 | 是 □否 | □不适用：_________ | | | 本次担保是否有反担 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603368 证券简称：柳药集团 公告编号：2025-058 转债代码：113563 转债简称：柳药转债 广西柳药集团股份有限公司 关于以集中竞价交易方式首次回购股份的公告 一、回购股份的基本情况 广西柳药集团股份有限公司（以下简称"公司"）于2025年7月25日召开第五届董事会第二十七次会议， 审议通过了《关于以集中竞价交易方式回购股份方案的议案》，同意公司使用自有资金和自筹资金通过 集中竞价交易方式回购部分公司A股股份，在未来适宜时机用于实施股权激励及/或员工持股计划。本次 回购资金总额不低于人民币10,000万元（含），不超过人民币20,000万元（含）；回购价格上限不超过 人民币25.70元/股（含）；回购期限为自董事会审议通过本次回购方案之日起不超过12个月。具体内容 详见公司分别于2025年7月26日、2025年8月5日在上海证券交易所网站（www.sse.com.cn）披露的《关 于以集中竞价交易方式回购股份方案的公告》（公告编号：2025-053）、《关于以集中竞价交易方式回 购股份的回购报告书》（公告编号：2025-056）。 二、 ...

截至2025年8月6日收盘，柳药集团股价报18.33元，较前一交易日下跌0.21元，跌幅1.13%。当日成交量 为102593手，成交金额达1.88亿元。 资金流向方面，8月6日主力资金净流出3280.16万元，近五日主力资金累计净流出272.08万元。 柳药集团是广西地区医药商业龙头企业，主营业务涵盖医药批发、零售和工业三大板块。2024年年报显 示，公司营业收入中批发业务占比78.89%，零售业务占比15.15%，工业业务占比5.49%。 公司8月6日晚间发布公告称，当日通过集中竞价交易方式首次回购股份54.45万股，占总股本0.14%，回 购金额998.28万元，回购价格区间为18.29元至18.36元。根据此前披露的回购方案，公司计划使用1-2亿 元资金进行回购，回购价格上限为25.70元/股，回购期限为12个月。 风险提示：以上内容仅供参考，不构成投资建议。市场有风险，投资需谨慎。 ...

| 证券代码：603368 | 证券简称：柳药集团 公告编号：2025-058 | | --- | --- | | 转债代码：113563 | 转债简称：柳药转债 | 广西柳药集团股份有限公司 关于以集中竞价交易方式首次回购股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，现将公司首次回购股份的情况公告如下： 2025 年 8 月 6 日，公司通过集中竞价交易方式首次回购股份数量为 54.45 万 股，已回购股份占公司目前总股本的比例为 0.14%，回购成交的最高价为 18.36 元 /股、最低价为 18.29 元/股，已支付的总金额为 998.28 万元（不含交易费用）。 上述回购股份进展符合相关法律法规的规定及公司回购股份方案的要求。 重要内容提示： | 回购方案首次披露日 | 2025/7/26 | | | | | | | --- | --- | --- | --- | --- | --- ...

Summary of Key Points Core Viewpoint - The company, Guangxi Liuyuan Group Co., Ltd., has announced a share repurchase plan to enhance investor confidence and implement employee stock ownership plans, with a total repurchase amount ranging from RMB 100 million to RMB 200 million [2][33]. Group 1: Repurchase Plan Details - The repurchase amount will not be less than RMB 100 million and not exceed RMB 200 million [2]. - The funding sources for the repurchase will be the company's own funds and self-raised funds, with a loan commitment from Industrial Bank Co., Ltd. for up to RMB 180 million [17]. - The repurchase price will not exceed RMB 25.70 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's decision [2][16]. - The repurchase will be conducted through centralized bidding and is expected to be completed within 12 months from the board's approval [3][11]. Group 2: Purpose and Use of Repurchased Shares - The purpose of the repurchase is to stabilize investor expectations, enhance market confidence, and implement employee stock ownership plans [8]. - If the repurchased shares are not used for the intended purposes within three years, they will be canceled [2][22]. Group 3: Shareholder and Management Plans - As of the board's decision date, there are no plans for share reduction by the company's directors, supervisors, and major shareholders in the next three to six months [4][20]. - The board approved the repurchase plan with unanimous consent, and it does not require shareholder meeting approval [7]. Group 4: Financial Impact and Company Status - As of March 31, 2025, the company's total assets were RMB 20.997 billion, and the repurchase amount will have a minimal impact on its financials, accounting for approximately 0.95% to 2.53% of various financial metrics [18][19]. - The company maintains a debt ratio of 60.87%, indicating that the repurchase will not significantly affect its debt repayment capacity [19]. Group 5: Progress and Compliance - As of July 31, 2025, the company has not yet repurchased any shares through the announced plan [34]. - The company will continue to comply with relevant regulations and disclose progress on the repurchase plan regularly [36].